Background Patients can form antibodies to foreign human leukocyte antigen (HLA) Class I antigens after exposure to allogeneic cells. These anti‐HLA class I antibodies can bind transfused platelets (PLTs) and mediate their destruction, thus leading to PLT refractoriness. Patients with PLT refractoriness need HLA‐matched PLTs, which require expensive HLA typing of donors, antibody analyses of patient sera and/or crossmatching. An alternative approach is to reduce PLT HLA Class I expression using a brief incubation in citric acid on ice at low pH. Methods and Materials Apheresis PLT concentrates were depleted of HLA Class I complexes by 5 minutes incubation in ice‐cold citric acid, at pH 3.0. Surface expression of HLA Class I complexes, CD6...
In adults, normal hematopoiesis occurs in the bone marrow, producing leukocytes, red blood cells, an...
Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with he...
Transfusion of blood components with residual leukocytes may lead to a number of adverse reactions b...
Purpose Refractoriness can occur after repeated platelet (PLT) transfusions because of alloimmuniza...
BACKGROUND: Platelet transfusions can induce alloimmunization against HLA antigens. The use of patho...
HLA‐Alloimmunization remains a significant problem in platelet transfusion therapy. HLA‐eluted plate...
Substitution of transfused platelet concentrates are often accused to cause HLA-antibody development...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
BACKGROUND: Exposure to allogeneic blood products often leads to the development of human leukocyte ...
Despite significant advancements in the production of platelet products, storage, and transfusion, t...
International audienceBackground: Patients with hematologic malignancies require prophylactic or cur...
• High, but not low to moderate, HLA antibody levels are associated with platelet refractoriness. In...
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...
Abstract Platelet (PLT) transfusion is indispensable to maintain homeostasis in thrombocytopenic pat...
In adults, normal hematopoiesis occurs in the bone marrow, producing leukocytes, red blood cells, an...
Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with he...
Transfusion of blood components with residual leukocytes may lead to a number of adverse reactions b...
Purpose Refractoriness can occur after repeated platelet (PLT) transfusions because of alloimmuniza...
BACKGROUND: Platelet transfusions can induce alloimmunization against HLA antigens. The use of patho...
HLA‐Alloimmunization remains a significant problem in platelet transfusion therapy. HLA‐eluted plate...
Substitution of transfused platelet concentrates are often accused to cause HLA-antibody development...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
BACKGROUND: Exposure to allogeneic blood products often leads to the development of human leukocyte ...
Despite significant advancements in the production of platelet products, storage, and transfusion, t...
International audienceBackground: Patients with hematologic malignancies require prophylactic or cur...
• High, but not low to moderate, HLA antibody levels are associated with platelet refractoriness. In...
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...
Abstract Platelet (PLT) transfusion is indispensable to maintain homeostasis in thrombocytopenic pat...
In adults, normal hematopoiesis occurs in the bone marrow, producing leukocytes, red blood cells, an...
Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with he...
Transfusion of blood components with residual leukocytes may lead to a number of adverse reactions b...